- Home
- VXRT vs CHMI Comparison
VXRT vs CHMI Comparison
Compare VXRT & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VXRT
- CHMI
- Stock Information
- Founded
- VXRT N/A
- CHMI 2012
- Country
- VXRT United States
- CHMI United States
- Employees
- VXRT N/A
- CHMI N/A
- Industry
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- CHMI Real Estate Investment Trusts
- Sector
- VXRT Health Care
- CHMI Real Estate
- Exchange
- VXRT Nasdaq
- CHMI Nasdaq
- Market Cap
- VXRT 119.0M
- CHMI 97.0M
- IPO Year
- VXRT N/A
- CHMI 2013
- Fundamental
- Price
- VXRT $0.58
- CHMI $2.96
- Analyst Decision
- VXRT Strong Buy
- CHMI Hold
- Analyst Count
- VXRT 2
- CHMI 2
- Target Price
- VXRT $3.00
- CHMI N/A
- AVG Volume (30 Days)
- VXRT 9.2M
- CHMI 182.2K
- Earning Date
- VXRT 08-07-2025
- CHMI 08-07-2025
- Dividend Yield
- VXRT N/A
- CHMI 20.34%
- EPS Growth
- VXRT N/A
- CHMI N/A
- EPS
- VXRT N/A
- CHMI N/A
- Revenue
- VXRT $47,395,000.00
- CHMI $27,506,000.00
- Revenue This Year
- VXRT N/A
- CHMI N/A
- Revenue Next Year
- VXRT N/A
- CHMI $54.92
- P/E Ratio
- VXRT N/A
- CHMI N/A
- Revenue Growth
- VXRT 433.43
- CHMI 19.59
- 52 Week Low
- VXRT $0.29
- CHMI $2.34
- 52 Week High
- VXRT $1.07
- CHMI $3.99
- Technical
- Relative Strength Index (RSI)
- VXRT 59.05
- CHMI 46.58
- Support Level
- VXRT $0.48
- CHMI $2.87
- Resistance Level
- VXRT $0.78
- CHMI $3.04
- Average True Range (ATR)
- VXRT 0.08
- CHMI 0.05
- MACD
- VXRT 0.02
- CHMI -0.01
- Stochastic Oscillator
- VXRT 50.00
- CHMI 41.18
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.